We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Arius Completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program

News   Jan 30, 2008

 
Arius Completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
 
 
Advertisement
 

RELATED ARTICLES

Neural Progenitor Cells Discovered in the Optic Nerve

News

Researchers at the University of Maryland School of Medicine have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and provides potential new ways to treat a leading cause of blindness in American adults.

READ MORE

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Pan-Bcl-2 and Bcl-xL-Specific Inhibitors: Adverse Effects From Cancer Drug Trials Explained

News

A certain type of cancer drug, known as pan-Bcl-2 or Bcl-xL-specific inhibitors, that promote the apotosis can actually be harmful if combined with other treatments that damage our DNA, RNA or proteins, researchers have found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE